Redmile Group VC
Investments by market, targeted sectors and preferred funding rounds
Investments by industry
biotech - 67%
healthtech - 33%
Number of investments: 6
Redmile Group invested in Entrada Therapeutics during a round worth $116,000,000 - 3/31/2021
Redmile Group invested in ElevateBio during a round worth $525,000,000 - 3/15/2021
Redmile Group invested in Amunix during a round worth $117,000,000 - 3/8/2021
Redmile Group invested in Evox Therapeutics during a round worth £69,200,000 - 2/18/2021
Redmile Group invested in Verve Therapeutics during a round worth $94,000,000 - 1/19/2021
Redmile Group invested in MedAvail during a round worth $84,000,000 - 11/19/2020